Table 6

Multivariate stepwise linear regression analysis of clinical and imaging variables associated with the degree of radiographic progression in the spine as measured by the mSASSS in the FORCAST cohort of patients with SpA

Regression modelAdjusted R2Significant variablesβ coefficientp Value
Primary model (age, sex, symptom duration, duration of follow-up, BL CRP, BL mSASSS, treatment)0.054Age0.011<0.001
Duration of follow-up0.0040.03
CRP0.0050.03
Primary model plus SSS fat metaplasia score0.14Age0.0110.002
Duration of follow-up0.0100.002
Fat metaplasia0.027<0.001
Primary model plus SSS erosion score0.10Age0.015<0.001
CRP0.0060.02
Duration of follow-up0.0110.002
Primary model plus SSS backfill score0.10Age0.015<0.001
CRP0.0060.016
Duration of follow-up0.0110.002
Primary model plus SSS ankylosis score0.10Age0.015<0.001
CRP0.0060.018
Duration of follow-up0.0110.002
Primary model plus SSS fat metaplasia, erosion, backfill, ankylosis scores0.15Age0.0100.01
Duration of follow-up0.0110.001
Fat metaplasia0.0250.001
Ankylosis0.0120.047
  • BL CRP, Basile C-reactive protein; FORCAST, Follow Up Research Cohort in Ankylosing Spondylitis; mSASSS, modified Stoke Ankylosing Spondylitis Spine Score; SpA, spondyloarthritis; SPARCC, Spondyloarthritis Research Consortium of Canada; SSS, SPARCC MRI SIJ Structural Scoring.